 Robert Breeze
Concepts (294)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 20 | 2011 | 462 | 1.100 |
Why?
| | Fetal Tissue Transplantation | 15 | 2004 | 35 | 1.050 |
Why?
| | Endolymphatic Hydrops | 2 | 2013 | 3 | 0.860 |
Why?
| | Meniere Disease | 2 | 2013 | 32 | 0.820 |
Why?
| | Trigeminal Neuralgia | 2 | 2019 | 16 | 0.670 |
Why?
| | Surgical Instruments | 3 | 2019 | 51 | 0.670 |
Why?
| | Microvascular Decompression Surgery | 1 | 2019 | 5 | 0.630 |
Why?
| | Polytetrafluoroethylene | 1 | 2019 | 24 | 0.630 |
Why?
| | Intracranial Aneurysm | 5 | 2018 | 95 | 0.500 |
Why?
| | Brain Tissue Transplantation | 8 | 2004 | 18 | 0.480 |
Why?
| | Cell Transplantation | 2 | 2011 | 37 | 0.450 |
Why?
| | Ear, Inner | 1 | 2013 | 45 | 0.420 |
Why?
| | Dopamine | 8 | 2009 | 286 | 0.370 |
Why?
| | Dopaminergic Neurons | 1 | 2011 | 57 | 0.350 |
Why?
| | Meningioma | 2 | 2009 | 82 | 0.350 |
Why?
| | Reperfusion Injury | 1 | 2013 | 272 | 0.350 |
Why?
| | Osteochondroma | 1 | 2009 | 7 | 0.330 |
Why?
| | Dura Mater | 1 | 2009 | 30 | 0.320 |
Why?
| | Meningeal Neoplasms | 2 | 2009 | 94 | 0.320 |
Why?
| | Clinical Trials as Topic | 3 | 2011 | 1005 | 0.280 |
Why?
| | Bone Neoplasms | 1 | 2009 | 229 | 0.270 |
Why?
| | Models, Biological | 1 | 2013 | 1724 | 0.260 |
Why?
| | Radiosurgery | 3 | 2018 | 321 | 0.250 |
Why?
| | Mesencephalon | 6 | 2003 | 66 | 0.250 |
Why?
| | Hemangioma, Cavernous | 2 | 2003 | 14 | 0.240 |
Why?
| | Brain Neoplasms | 5 | 2018 | 1149 | 0.240 |
Why?
| | Craniotomy | 4 | 2019 | 68 | 0.200 |
Why?
| | Mutism | 1 | 2002 | 5 | 0.190 |
Why?
| | Dihydroxyphenylalanine | 4 | 2009 | 9 | 0.190 |
Why?
| | Central Nervous System Neoplasms | 1 | 2003 | 149 | 0.180 |
Why?
| | Brain Stem Neoplasms | 1 | 2002 | 81 | 0.180 |
Why?
| | Cerebral Hemorrhage | 1 | 2002 | 105 | 0.180 |
Why?
| | Subarachnoid Hemorrhage | 2 | 2018 | 64 | 0.180 |
Why?
| | Nerve Fibers | 1 | 2001 | 91 | 0.180 |
Why?
| | Neurons | 4 | 2003 | 1509 | 0.170 |
Why?
| | Humans | 51 | 2019 | 129847 | 0.160 |
Why?
| | Tomography, Emission-Computed | 7 | 2003 | 66 | 0.150 |
Why?
| | Loeys-Dietz Syndrome | 1 | 2018 | 6 | 0.140 |
Why?
| | CTLA-4 Antigen | 1 | 2018 | 87 | 0.140 |
Why?
| | Carotid Artery Injuries | 1 | 1998 | 41 | 0.140 |
Why?
| | Aneurysm, Ruptured | 1 | 2018 | 34 | 0.140 |
Why?
| | Middle Aged | 28 | 2017 | 31177 | 0.140 |
Why?
| | Adult | 25 | 2017 | 35634 | 0.140 |
Why?
| | Choroid Plexus Neoplasms | 1 | 1997 | 8 | 0.140 |
Why?
| | Papilloma | 1 | 1997 | 48 | 0.130 |
Why?
| | Brain | 8 | 2009 | 2677 | 0.130 |
Why?
| | Aged | 18 | 2018 | 22107 | 0.130 |
Why?
| | Substantia Nigra | 3 | 2004 | 55 | 0.130 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2018 | 232 | 0.130 |
Why?
| | Antibodies | 1 | 2018 | 399 | 0.130 |
Why?
| | Antiparkinson Agents | 5 | 2003 | 28 | 0.130 |
Why?
| | Intracranial Arteriovenous Malformations | 2 | 2009 | 50 | 0.130 |
Why?
| | Parietal Bone | 1 | 1995 | 8 | 0.120 |
Why?
| | Quadriplegia | 1 | 1995 | 12 | 0.120 |
Why?
| | Bone Cysts | 1 | 1995 | 9 | 0.120 |
Why?
| | Rhabdomyolysis | 1 | 1995 | 22 | 0.120 |
Why?
| | Epidermal Cyst | 1 | 1995 | 12 | 0.120 |
Why?
| | Magnetic Resonance Imaging | 10 | 2009 | 3397 | 0.120 |
Why?
| | Age Factors | 5 | 2013 | 3161 | 0.120 |
Why?
| | Head Injuries, Closed | 1 | 1995 | 48 | 0.120 |
Why?
| | Male | 30 | 2018 | 63759 | 0.120 |
Why?
| | Levodopa | 3 | 2004 | 30 | 0.120 |
Why?
| | Fibromuscular Dysplasia | 1 | 2014 | 7 | 0.120 |
Why?
| | Wounds, Nonpenetrating | 1 | 1998 | 273 | 0.110 |
Why?
| | Double-Blind Method | 9 | 2009 | 1877 | 0.110 |
Why?
| | Ehlers-Danlos Syndrome | 1 | 2014 | 15 | 0.110 |
Why?
| | Brain Diseases | 1 | 1995 | 134 | 0.110 |
Why?
| | Aged, 80 and over | 2 | 2018 | 7066 | 0.110 |
Why?
| | Lymphoma | 2 | 2003 | 198 | 0.110 |
Why?
| | Neurofibromatosis 1 | 1 | 2014 | 50 | 0.110 |
Why?
| | Cerebral Arteries | 1 | 2014 | 60 | 0.110 |
Why?
| | Collagen | 1 | 1996 | 438 | 0.110 |
Why?
| | False Negative Reactions | 1 | 2013 | 53 | 0.110 |
Why?
| | Audiometry, Evoked Response | 1 | 2013 | 11 | 0.110 |
Why?
| | Female | 25 | 2018 | 68829 | 0.110 |
Why?
| | Alleles | 1 | 1996 | 843 | 0.110 |
Why?
| | Melanoma | 2 | 2018 | 730 | 0.110 |
Why?
| | Autopsy | 1 | 2013 | 92 | 0.100 |
Why?
| | Pineal Gland | 2 | 1997 | 16 | 0.100 |
Why?
| | Temporal Bone | 1 | 2013 | 49 | 0.100 |
Why?
| | Treatment Outcome | 10 | 2018 | 10241 | 0.100 |
Why?
| | Cerebral Ventricles | 2 | 1991 | 50 | 0.100 |
Why?
| | Chickenpox | 1 | 2013 | 80 | 0.100 |
Why?
| | Pressure | 1 | 2013 | 240 | 0.100 |
Why?
| | Spinal Cord Injuries | 1 | 1995 | 194 | 0.100 |
Why?
| | Dyskinesias | 2 | 2002 | 19 | 0.100 |
Why?
| | Terminology as Topic | 1 | 2013 | 204 | 0.090 |
Why?
| | Data Interpretation, Statistical | 1 | 2013 | 338 | 0.090 |
Why?
| | Pseudotumor Cerebri | 1 | 1991 | 25 | 0.090 |
Why?
| | Intracranial Pressure | 1 | 1991 | 45 | 0.090 |
Why?
| | Follow-Up Studies | 8 | 2009 | 4896 | 0.090 |
Why?
| | Postoperative Complications | 2 | 2002 | 2481 | 0.090 |
Why?
| | Nerve Tissue | 1 | 1990 | 7 | 0.090 |
Why?
| | Skull Neoplasms | 2 | 2003 | 22 | 0.090 |
Why?
| | Embryonic Stem Cells | 1 | 2011 | 118 | 0.090 |
Why?
| | Hydrocephalus | 1 | 1991 | 103 | 0.090 |
Why?
| | Spinal Cord Diseases | 1 | 1990 | 41 | 0.090 |
Why?
| | Cysts | 1 | 1990 | 108 | 0.080 |
Why?
| | Herpes Zoster | 1 | 2013 | 317 | 0.080 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 1050 | 0.080 |
Why?
| | Radiopharmaceuticals | 1 | 2009 | 168 | 0.080 |
Why?
| | Statistics as Topic | 1 | 2009 | 306 | 0.080 |
Why?
| | Cerebrospinal Fluid | 1 | 1989 | 92 | 0.080 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2009 | 182 | 0.070 |
Why?
| | Point Mutation | 1 | 2009 | 224 | 0.070 |
Why?
| | Microtubule-Associated Proteins | 1 | 2009 | 192 | 0.070 |
Why?
| | Acute Kidney Injury | 1 | 1995 | 791 | 0.070 |
Why?
| | Iridium | 1 | 1987 | 7 | 0.070 |
Why?
| | Radioisotopes | 1 | 1987 | 31 | 0.070 |
Why?
| | Pinealoma | 1 | 1987 | 10 | 0.070 |
Why?
| | Encephalitis | 1 | 1989 | 131 | 0.070 |
Why?
| | Fetus | 2 | 1990 | 782 | 0.070 |
Why?
| | Brachytherapy | 1 | 1987 | 104 | 0.060 |
Why?
| | Magnetic Resonance Angiography | 2 | 2018 | 234 | 0.060 |
Why?
| | Proto-Oncogene Proteins | 1 | 2009 | 634 | 0.060 |
Why?
| | Disease Progression | 3 | 2018 | 2628 | 0.060 |
Why?
| | Adolescent | 7 | 2014 | 20451 | 0.060 |
Why?
| | Risk Factors | 2 | 2013 | 9801 | 0.060 |
Why?
| | Lung Neoplasms | 1 | 2017 | 2344 | 0.060 |
Why?
| | Incidence | 2 | 2003 | 2646 | 0.060 |
Why?
| | Dopamine Agents | 1 | 2004 | 16 | 0.060 |
Why?
| | Transplantation | 1 | 2004 | 31 | 0.060 |
Why?
| | Glioblastoma | 2 | 2003 | 322 | 0.060 |
Why?
| | Putamen | 6 | 2003 | 22 | 0.050 |
Why?
| | Young Adult | 3 | 2017 | 12467 | 0.050 |
Why?
| | Endothelial Cells | 1 | 2009 | 749 | 0.050 |
Why?
| | Cerebral Angiography | 3 | 1998 | 108 | 0.050 |
Why?
| | Transplants | 1 | 2003 | 35 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2009 | 1951 | 0.050 |
Why?
| | Glioma | 1 | 1987 | 351 | 0.050 |
Why?
| | Granuloma, Foreign-Body | 1 | 2003 | 10 | 0.050 |
Why?
| | Transplantation, Heterologous | 1 | 2003 | 191 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2009 | 1119 | 0.050 |
Why?
| | Embryo, Mammalian | 1 | 2003 | 224 | 0.050 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2003 | 307 | 0.050 |
Why?
| | Combined Modality Therapy | 4 | 2018 | 1201 | 0.050 |
Why?
| | Parkinsonian Disorders | 1 | 2002 | 34 | 0.050 |
Why?
| | Reaction Time | 1 | 2004 | 411 | 0.050 |
Why?
| | Stem Cell Transplantation | 1 | 2003 | 166 | 0.050 |
Why?
| | Dysarthria | 1 | 2002 | 8 | 0.050 |
Why?
| | Cerebellar Nuclei | 1 | 2002 | 9 | 0.050 |
Why?
| | Preoperative Care | 1 | 2004 | 337 | 0.050 |
Why?
| | Laminectomy | 2 | 1999 | 29 | 0.050 |
Why?
| | Confidence Intervals | 1 | 2002 | 318 | 0.050 |
Why?
| | Globus Pallidus | 1 | 2001 | 23 | 0.050 |
Why?
| | Child, Preschool | 2 | 2013 | 10522 | 0.050 |
Why?
| | Control Groups | 1 | 2001 | 11 | 0.050 |
Why?
| | Cholesterol | 1 | 2003 | 412 | 0.040 |
Why?
| | Thalamus | 1 | 2002 | 100 | 0.040 |
Why?
| | Electric Stimulation Therapy | 1 | 2001 | 77 | 0.040 |
Why?
| | Movement | 3 | 2009 | 270 | 0.040 |
Why?
| | ErbB Receptors | 1 | 2003 | 605 | 0.040 |
Why?
| | Neural Pathways | 1 | 2002 | 301 | 0.040 |
Why?
| | Stereotaxic Techniques | 3 | 1995 | 37 | 0.040 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2009 | 739 | 0.040 |
Why?
| | Spinal Stenosis | 1 | 1999 | 27 | 0.040 |
Why?
| | Placebos | 1 | 2000 | 201 | 0.040 |
Why?
| | Child | 4 | 2018 | 20962 | 0.040 |
Why?
| | Motor Activity | 1 | 2004 | 684 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2003 | 1690 | 0.040 |
Why?
| | Intervertebral Disc Displacement | 1 | 1999 | 39 | 0.040 |
Why?
| | Prospective Studies | 2 | 2002 | 7158 | 0.040 |
Why?
| | Smooth Muscle Tumor | 1 | 1998 | 6 | 0.040 |
Why?
| | Sarcoma, Synovial | 1 | 1998 | 17 | 0.040 |
Why?
| | Genotype | 2 | 2009 | 1829 | 0.040 |
Why?
| | Leiomyosarcoma | 1 | 1998 | 26 | 0.040 |
Why?
| | Dobutamine | 1 | 1998 | 37 | 0.040 |
Why?
| | Ligation | 1 | 2018 | 87 | 0.040 |
Why?
| | Aortography | 1 | 1998 | 51 | 0.040 |
Why?
| | Blood Volume | 1 | 1998 | 61 | 0.040 |
Why?
| | Gene Expression | 1 | 2003 | 1465 | 0.040 |
Why?
| | Lumbar Vertebrae | 1 | 1999 | 234 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2018 | 422 | 0.030 |
Why?
| | Leiomyoma | 1 | 1998 | 73 | 0.030 |
Why?
| | Cell Nucleolus | 1 | 1997 | 17 | 0.030 |
Why?
| | Adrenergic beta-Agonists | 1 | 1998 | 133 | 0.030 |
Why?
| | Inclusion Bodies | 1 | 1997 | 23 | 0.030 |
Why?
| | Drainage | 1 | 2018 | 164 | 0.030 |
Why?
| | Animals | 5 | 2011 | 35409 | 0.030 |
Why?
| | Blotting, Southern | 1 | 1996 | 70 | 0.030 |
Why?
| | DNA Probes | 1 | 1996 | 60 | 0.030 |
Why?
| | Carotid Arteries | 1 | 1998 | 196 | 0.030 |
Why?
| | Postoperative Care | 1 | 2018 | 244 | 0.030 |
Why?
| | Cytoplasm | 1 | 1997 | 269 | 0.030 |
Why?
| | Cerebrovascular Circulation | 1 | 1998 | 228 | 0.030 |
Why?
| | Prevalence | 1 | 2002 | 2564 | 0.030 |
Why?
| | Caudate Nucleus | 4 | 2002 | 20 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 3 | 1995 | 2511 | 0.030 |
Why?
| | Vision Disorders | 1 | 1997 | 135 | 0.030 |
Why?
| | Immobilization | 1 | 1995 | 43 | 0.030 |
Why?
| | Aorta, Thoracic | 1 | 1998 | 263 | 0.030 |
Why?
| | Micromanipulation | 1 | 1995 | 14 | 0.030 |
Why?
| | Retrospective Studies | 3 | 2018 | 14553 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2017 | 610 | 0.030 |
Why?
| | Brain Edema | 1 | 1995 | 61 | 0.030 |
Why?
| | Visual Acuity | 1 | 1997 | 326 | 0.030 |
Why?
| | Brain Ischemia | 1 | 1998 | 321 | 0.030 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 1995 | 170 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2001 | 2739 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2000 | 1368 | 0.030 |
Why?
| | Intraoperative Complications | 1 | 1995 | 129 | 0.030 |
Why?
| | Equipment Design | 1 | 1995 | 514 | 0.030 |
Why?
| | Receptors, Dopamine | 1 | 1993 | 16 | 0.030 |
Why?
| | Radiography | 1 | 1995 | 800 | 0.030 |
Why?
| | Brain Stem | 2 | 1992 | 100 | 0.030 |
Why?
| | Nerve Regeneration | 1 | 1993 | 62 | 0.020 |
Why?
| | Emergency Medical Services | 1 | 1998 | 522 | 0.020 |
Why?
| | Fluorine Radioisotopes | 2 | 2002 | 12 | 0.020 |
Why?
| | Neurologic Examination | 4 | 1993 | 114 | 0.020 |
Why?
| | Body Water | 1 | 1991 | 20 | 0.020 |
Why?
| | Acute Disease | 2 | 1998 | 980 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2018 | 2724 | 0.020 |
Why?
| | Syndrome | 1 | 1991 | 338 | 0.020 |
Why?
| | Adrenal Glands | 1 | 1990 | 70 | 0.020 |
Why?
| | Neostriatum | 1 | 2009 | 33 | 0.020 |
Why?
| | KRIT1 Protein | 1 | 2009 | 4 | 0.020 |
Why?
| | Corpus Striatum | 1 | 1990 | 154 | 0.020 |
Why?
| | Escherichia coli Infections | 1 | 1989 | 108 | 0.020 |
Why?
| | Positron-Emission Tomography | 1 | 2009 | 282 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2009 | 379 | 0.020 |
Why?
| | DNA, Neoplasm | 1 | 1988 | 154 | 0.020 |
Why?
| | Gene Frequency | 1 | 2009 | 500 | 0.020 |
Why?
| | Rabbits | 1 | 1989 | 778 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1992 | 2016 | 0.020 |
Why?
| | Time Factors | 4 | 1999 | 6550 | 0.020 |
Why?
| | Pituitary Neoplasms | 1 | 1988 | 180 | 0.020 |
Why?
| | Quality of Life | 1 | 1998 | 2695 | 0.020 |
Why?
| | Sex Factors | 1 | 2009 | 1973 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 1988 | 660 | 0.010 |
Why?
| | Trigeminal Nerve | 1 | 1982 | 28 | 0.010 |
Why?
| | Corpus Callosum | 1 | 2003 | 65 | 0.010 |
Why?
| | Temporal Arteries | 1 | 2003 | 45 | 0.010 |
Why?
| | Temporal Lobe | 1 | 2003 | 86 | 0.010 |
Why?
| | Treatment Failure | 1 | 2003 | 339 | 0.010 |
Why?
| | Rats | 1 | 1990 | 5487 | 0.010 |
Why?
| | Frontal Lobe | 1 | 2003 | 154 | 0.010 |
Why?
| | Psychomotor Performance | 1 | 2004 | 312 | 0.010 |
Why?
| | Culture Techniques | 1 | 2001 | 81 | 0.010 |
Why?
| | Walking | 2 | 1999 | 500 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2003 | 756 | 0.010 |
Why?
| | Down-Regulation | 1 | 2003 | 631 | 0.010 |
Why?
| | Reoperation | 1 | 1982 | 542 | 0.010 |
Why?
| | Work | 1 | 1999 | 17 | 0.010 |
Why?
| | Up-Regulation | 1 | 2003 | 836 | 0.010 |
Why?
| | Vascular Surgical Procedures | 1 | 1982 | 295 | 0.010 |
Why?
| | Recurrence | 1 | 1982 | 1013 | 0.010 |
Why?
| | Ethics, Medical | 1 | 2000 | 78 | 0.010 |
Why?
| | Lumbosacral Region | 1 | 1999 | 55 | 0.010 |
Why?
| | Stem Cells | 1 | 2003 | 578 | 0.010 |
Why?
| | Neuropsychological Tests | 1 | 2003 | 1016 | 0.010 |
Why?
| | Sella Turcica | 1 | 1998 | 16 | 0.010 |
Why?
| | Tumor Virus Infections | 1 | 1998 | 46 | 0.010 |
Why?
| | Low Back Pain | 1 | 1999 | 105 | 0.010 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 1998 | 64 | 0.010 |
Why?
| | Biomarkers | 1 | 1988 | 3971 | 0.010 |
Why?
| | Risk | 1 | 2000 | 860 | 0.010 |
Why?
| | Fatal Outcome | 1 | 1998 | 300 | 0.010 |
Why?
| | Herpesvirus 4, Human | 1 | 1998 | 157 | 0.010 |
Why?
| | Herpesviridae Infections | 1 | 1998 | 142 | 0.010 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 1998 | 228 | 0.010 |
Why?
| | Spinal Fusion | 1 | 1999 | 233 | 0.010 |
Why?
| | Pain | 1 | 1982 | 791 | 0.010 |
Why?
| | Arteries | 1 | 1997 | 266 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2003 | 2703 | 0.010 |
Why?
| | Antibody-Dependent Cell Cytotoxicity | 1 | 1995 | 20 | 0.010 |
Why?
| | Muscle Contraction | 1 | 1998 | 423 | 0.010 |
Why?
| | Vasodilation | 1 | 1998 | 476 | 0.010 |
Why?
| | Cytotoxicity, Immunologic | 1 | 1995 | 220 | 0.010 |
Why?
| | RNA, Viral | 1 | 1998 | 620 | 0.010 |
Why?
| | Length of Stay | 1 | 1999 | 1133 | 0.010 |
Why?
| | Primates | 1 | 1995 | 120 | 0.010 |
Why?
| | Prednisone | 1 | 1995 | 234 | 0.010 |
Why?
| | Cyclosporine | 1 | 1995 | 263 | 0.010 |
Why?
| | Transplantation, Homologous | 1 | 1995 | 402 | 0.010 |
Why?
| | Antibody Formation | 1 | 1995 | 291 | 0.010 |
Why?
| | Tissue Survival | 1 | 1992 | 16 | 0.010 |
Why?
| | Immunity, Cellular | 1 | 1995 | 265 | 0.010 |
Why?
| | Dominance, Cerebral | 1 | 1993 | 54 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 1997 | 1847 | 0.010 |
Why?
| | Spleen | 1 | 1995 | 508 | 0.010 |
Why?
| | Cohort Studies | 1 | 2002 | 5444 | 0.010 |
Why?
| | Lymph Nodes | 1 | 1995 | 471 | 0.010 |
Why?
| | Video Recording | 1 | 1992 | 164 | 0.010 |
Why?
| | Spinal Cord | 1 | 1992 | 355 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1990 | 176 | 0.010 |
Why?
| | Activities of Daily Living | 1 | 1992 | 384 | 0.000 |
Why?
| | Cell Line | 1 | 1995 | 2780 | 0.000 |
Why?
| | Motor Skills | 1 | 1990 | 93 | 0.000 |
Why?
| | Antigens, Nuclear | 1 | 1988 | 19 | 0.000 |
Why?
| | Aneuploidy | 1 | 1988 | 92 | 0.000 |
Why?
| | Pituitary Gland | 1 | 1988 | 148 | 0.000 |
Why?
| | Fluorescent Antibody Technique | 1 | 1988 | 377 | 0.000 |
Why?
| | Cell Cycle | 1 | 1988 | 583 | 0.000 |
Why?
| | Flow Cytometry | 1 | 1988 | 1160 | 0.000 |
Why?
|
|
Breeze's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|